First Line Therapy for High Risk Acute GVHD

Conditions:   aGVHD;   Stem Cell Transplant Complications Interventions:   Drug: Ruxolitinib;   Drug: Corticosteroid Sponsor:   Chinese PLA General Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials